|Last Price$37.03||Day Change (%)1.81%|
|Open Price$35.54||Day Change ($)0.66|
|Day Range35.06–37.49||52-Week Range12.17–45.36|
As of Thu 3/26/2015 4:33:00 PM | USD
On Monday, Neurocrine Biosciences NBIX accelerated its anticipated filing date for indiplon capsules to the second quarter of 2007 instead of 2009. We're placing Neurocrine under review while we revisit our assumptions, and because DOV Pharmaceutical DOVP is entitled to a royalty on any indiplon ...
UPDATE: These are the most profitable Nasdaq biotech companies
UPDATE: These are the most profitable Nasdaq -2-